Song Y - Search Results

1

Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first-line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open-label, parallel controlled clinical study.

Zhang J, Pan Y, Shi Q, Zhang G, Jiang L, Dong X, Gu K, Wang H, Zhang X, Yang N, Li Y, Xiong J, Yi T, Peng M, Song Y, Fan Y, Cui J, Chen G, Tan W, Zang A, Guo Q, Zhao G, Wang Z, He J, Yao W, Wu X, Chen K, Hu X, Hu C, Yue L, Jiang D, Wang G, Liu J, Yu G, Li J, Bai J, Xie W, Zhao W, Wu L, Zhou C. Zhang J, et al. Among authors: song y. Cancer Commun (Lond). 2022 Jan;42(1):3-16. doi: 10.1002/cac2.12225. Epub 2021 Oct 26. Cancer Commun (Lond). 2022. PMID: 34699693 Free PMC article. Clinical Trial.

2

Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis.

Wei SZ, Zhan P, Shi MQ, Shi Y, Qian Q, Yu LK, Song Y. Wei SZ, et al. Among authors: song y. Med Oncol. 2011 Mar;28(1):315-21. doi: 10.1007/s12032-010-9443-1. Epub 2010 Feb 9. Med Oncol. 2011. PMID: 20143185 Review.

3

Baseline and decline of serum ADAM28 during chemotherapy of advanced non-small cell lung cancer: a probable predictive and prognostic factor.

Lv YL, Yuan DM, Wang QB, Zhan P, Luo L, Lv TF, Liu HB, Li YF, Wen J, Song Y. Lv YL, et al. Among authors: song y. Med Oncol. 2012 Dec;29(4):2633-9. doi: 10.1007/s12032-012-0180-5. Epub 2012 Feb 22. Med Oncol. 2012. PMID: 22354764

4

Chemotherapy plus multitargeted antiangiogenic tyrosine kinase inhibitors or chemotherapy alone in advanced NSCLC: a meta-analysis of randomized controlled trials.

Xiao YY, Zhan P, Yuan DM, Liu HB, Lv TF, Song Y, Shi Y. Xiao YY, et al. Among authors: song y. Eur J Clin Pharmacol. 2013 Feb;69(2):151-9. doi: 10.1007/s00228-012-1333-3. Epub 2012 Jun 24. Eur J Clin Pharmacol. 2013. PMID: 22729611 Clinical Trial.

5

Single-agent maintenance therapy in non-small cell lung cancer: a systematic review and meta-analysis.

Yuan DM, Wei SZ, Lü YL, Zhang Y, Miao XH, Zhan P, Yu LK, Shi Y, Song Y. Yuan DM, et al. Among authors: song y. Chin Med J (Engl). 2012 Sep;125(17):3143-9. Chin Med J (Engl). 2012. PMID: 22932196 Review.

6

Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.

Yao Y, Yuan D, Liu H, Gu X, Song Y. Yao Y, et al. Among authors: song y. Cancer Immunol Immunother. 2013 Mar;62(3):471-9. doi: 10.1007/s00262-012-1347-9. Epub 2012 Sep 18. Cancer Immunol Immunother. 2013. PMID: 22986452 Free PMC article.

7

Chemotherapy plus Vandetanib or chemotherapy alone in advanced non-small cell lung cancer: a meta-analysis of four randomised controlled trials.

Xiao YY, Zhan P, Yuan DM, Liu HB, Lv TF, Shi Y, Song Y. Xiao YY, et al. Among authors: song y. Clin Oncol (R Coll Radiol). 2013 Jan;25(1):e7-e15. doi: 10.1016/j.clon.2012.09.005. Epub 2012 Nov 21. Clin Oncol (R Coll Radiol). 2013. PMID: 23177099

8

Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial.

Shi Y, Zhang L, Liu X, Zhou C, Zhang L, Zhang S, Wang D, Li Q, Qin S, Hu C, Zhang Y, Chen J, Cheng Y, Feng J, Zhang H, Song Y, Wu YL, Xu N, Zhou J, Luo R, Bai C, Jin Y, Liu W, Wei Z, Tan F, Wang Y, Ding L, Dai H, Jiao S, Wang J, Liang L, Zhang W, Sun Y. Shi Y, et al. Among authors: song y. Lancet Oncol. 2013 Sep;14(10):953-61. doi: 10.1016/S1470-2045(13)70355-3. Epub 2013 Aug 13. Lancet Oncol. 2013. PMID: 23948351 Clinical Trial.

9

The role of serum carcinoembryonic antigen in predicting responses to chemotherapy and survival in patients with non-small cell lung cancer.

Liu H, Gu X, Lv T, Wu Y, Xiao Y, Yuan D, Li Y, Song Y. Liu H, et al. Among authors: song y. J Cancer Res Ther. 2014 Apr-Jun;10(2):239-43. doi: 10.4103/0973-1482.136541. J Cancer Res Ther. 2014. PMID: 25022372 Free article.

10

A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung.

Yang JJ, Huang C, Chen GY, Song Y, Cheng Y, Yan HH, Zhou Q, Wu YL. Yang JJ, et al. Among authors: song y. BMC Cancer. 2014 Sep 20;14:684. doi: 10.1186/1471-2407-14-684. BMC Cancer. 2014. PMID: 25239521 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38,130 results

Search Page

Filters